drugset / Trial / NCT02386319

Anxiolytic and Analgesic Effects of Melatonin

NCT02386319

Phase 3 Completed 36 enrolled Herlev Hospital
RandomizedParallel-groupTriple-blindTreatment

Summary

The study's main objective is to investigate melatonin's anxiolytic and sleep-regulating effects in patients undergoing surgery. Moreover, the investigators intend to investigate the pharmacokinetic parameters of melatonin in this patient population.

Timeline

Start
2016-08
Primary completion
2021-03
Completion
2021-04

Drugs

EvaluationDrugModalityDoseRoute
Comparator Melatonin Small molecule 10 mg

Indications